INBX - Inhibrx Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

649.3M

Cash

192.5M

Avg Qtr Burn

-35.92M

Short % of Float

28.46%

Insider Ownership

21.61%

Institutional Own.

85.31%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
INBRX-101 (AAT-Fc fusion protein) Details Genetic disorder, Severe alpha-1 antitrypsin deficiency, Rare genetic disease, Emphysema due to Alpha-1 Antitrypsin Deficiency	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INBRX-109 (DR5 agonist) Details Solid tumor/s, Cancer, Chondrosarcoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INBRX-109 (DR5 agonist) Details Relapsed/refractory Ewing sarcoma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INBRX-106 (OX40 agonist) +/- Keytruda Details Solid tumor/s, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INBRX-105 (PDL1 X 4-1BB tetravalent conditional agonist) +/- Keytruda Details Solid tumor/s, Cancer	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.